The Effect of Pure Prone Positioning Therapy for the Patients With Mild to Moderate Obstructive Sleep Apnea
This study has been completed.
Sponsor:
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Information provided by:
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT01368952
First received: June 6, 2011
Last updated: June 7, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Efficacy of Pure Prone Positioning (PPP) treatment in improving apnea-hypopnea index (AHI) and nocturnal oxygen saturation was investigated in mild to moderate Obstructive Sleep Apnea.
| Condition | Intervention |
|---|---|
|
Obstructive Sleep Apnea |
Device: Pure prone positioning |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Efficacy Study of Pure Prone Positioning Therapy in Patients With Mild to Moderate Obstructive Sleep Apnea |
Resource links provided by NLM:
Further study details as provided by Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital:
Primary Outcome Measures:
- Apnea-hypopnea index (AHI) [ Time Frame: ''Baseline PSG night'' and ''pure prone positioning night within two weeks of baseline PSG night'' ] [ Designated as safety issue: No ]Reduction in AHI during pure positioning night as compared to baseline night
Secondary Outcome Measures:
- Nocturnal oxygen saturation [ Time Frame: ''Baseline PSG night'' and ''pure prone positioning night within two weeks of baseline PSG night'' ] [ Designated as safety issue: No ]Comparison of mean oxygen saturation, minimum oxygen saturation and proportion of time spent during sleep with oxygen saturation below 90% (as measures of nocturnal hypoxemia) in pure prone positioning night with that of the baseline night.
- Sleep efficiency [ Time Frame: ''Baseline PSG night'' and ''pure prone positioning night within two weeks of baseline PSG night'' ] [ Designated as safety issue: No ]Improvement in sleep efficiency in prone positioning night as compared to baseline night.
| Enrollment: | 29 |
| Study Start Date: | March 2011 |
| Study Completion Date: | May 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Pure Prone Positioning
Sleeping in prone position by pure prone positioning device, which consisted of a pillow mounted on a table designed to keep the subjects sleeping prone.
|
Device: Pure prone positioning
Pure prone positioning device consisted of a pillow mounted on a table designed to keep the subjects sleeping prone.
Other Name: Positional treatment
|
|
No Intervention: Baseline
No intervention for sleep position
|
Detailed Description:
Sleeping in prone position could be effective in the management of obstructive sleep apnea (OSA) by reducing the gravity effect on the upper airway and hence collapsibility. Pure prone positioning (PPP) consisted of a pillow mounted on a table designed to keep the subjects sleeping prone with the head extended in line with the body.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients were enrolled to the study among one hundred and eighty-four consecutive patients who were admitted to our sleep center with 6 beds in a tertiary care hospital, during 3 months period. Of these, 36 patients with mild to moderate OSA (AHI=5-30 events/h) were invited to participate in the study based on the selection criteria, and 29 patients with mild to moderate OSA on their baseline PSG, (17 males, 12 females) gave informed consent and participated in the study.
Exclusion Criteria:
- Patients having BMI>35 and/or abdominal and/or trunkal obesity that may hinder prone sleeping , upper airway pathology (nasal polyp, nasal turbinate hypertrophy, chronic sinusitis, nasal septum deviation, upper airway infection, Mallampati score and tonsil size grade of IV), any other concomitant sleep disorder (narcolepsy, periodic leg movement syndrome, insomnia, sleep related hypoventilation-hypoxemia and central sleep apnea syndrome), psychiatric disorder such as panic disorder, heart failure and coronary artery disease were not included in the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01368952
Locations
| Turkey | |
| The Department of Sleep Disorders, Izmir Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital | |
| Izmir, Turkey, 35110 | |
Sponsors and Collaborators
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Investigators
| Principal Investigator: | Arman Afrashi, MD | The Department of Otolaryngology-Head and Neck Surgery, Izmir Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey |
| Study Director: | Zeynep Z Ucar, MD | The Department of Sleep Disorders, Izmir Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey |
More Information
Publications:
| Responsible Party: | Arman Afrashi, MD., Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital |
| ClinicalTrials.gov Identifier: | NCT01368952 History of Changes |
| Other Study ID Numbers: | IGHCEAH-IRB-286, 286 |
| Study First Received: | June 6, 2011 |
| Last Updated: | June 7, 2011 |
| Health Authority: | Turkey: Ministry of Health |
Keywords provided by Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital:
|
Obstructive Sleep Apnea Prone positioning Positional Treatment Hypoxemia |
Additional relevant MeSH terms:
|
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Disorders Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013